Women’s Health

November 10, 2022

Study to explore nasal bacteria of children born by C-section

Vanderbilt is recruiting pregnant women scheduled to undergo a repeat cesarean section at VUMC for a study of potential interventions to change the bacteria living in the nose of children born by C-section.

By Nancy Humphrey
August 17, 2022

Lindley named to direct new multidisciplinary Women’s Heart Center

Kathryn Lindley, MD, has joined the Vanderbilt Heart and Vascular Institute as director of the new Women’s Heart Center.

By Matt Batcheldor
Pregnant woman holding pill pack
August 2, 2022

Targeted cancer drug during pregnancy

The targeted cancer therapy alectinib was safe as a treatment for lung cancer during two pregnancies in a patient with non-small cell lung cancer, according to a case report from Vanderbilt physicians.

By Leigh MacMillan
July 15, 2022

VUMC, Tennova Healthcare – Clarksville collaborate to provide OB-GYN hospitalist care

Expectant women in Clarksville, Montgomery County and the surrounding area will soon benefit from around-the-clock, enhanced medical care during their labor and delivery through a collaboration between Vanderbilt University Medical Center and Tennova Healthcare – Clarksville to establish an OB-GYN hospitalist program.

By Jill Clendening
July 6, 2022

Study shows two vaccine doses for mothers eases COVID complications for infants

Infants younger than 6 months were better protected from COVID-19 complications when mothers received two doses of the vaccine while pregnant, according to Vanderbilt researchers.

By Jessica Pasley
June 9, 2022

Filling multiple opioid prescriptions after childbirth associated with maternal death risk

In a new study led by Vanderbilt University Medical Center researchers, women who filled two or more prescriptions for opioids after childbirth faced a 46% greater risk of death than women who did not.

By Jake Lowary
May 24, 2022

Vanderbilt Center for Women’s Health merges with Women’s Health Center of Lebanon

Vanderbilt Center for Women’s Health will merge with Women’s Health Center of Lebanon (WHCL) on May 28, expanding access to care.
By Emily Stembridge
April 26, 2022

Calculating risk for uterine fibroids

Vanderbilt researchers have constructed a polygenic risk score for uterine fibroids that will be useful for exploring causes of these benign tumors and identifying novel drug targets and therapies.
By Leigh MacMillan
March 28, 2022

Rheumatoid arthritis: special deliveries

Birth outcomes including postpartum infection and blood transfusion were similar in women with and without rheumatoid arthritis, and continued use of disease-modifying antirheumatic drugs and biologics is recommended to limit steroid exposure.
By Bill Snyder
March 15, 2022

Improving care for gynecologic cancer

To reduce risk of deep vein thrombosis in patients being treated for gynecologic cancer, Vanderbilt researchers recommend that providers use Khorana scores and provide prophylactic treatment according to clinical guidelines.
By Emily Stembridge
February 28, 2022

Invasive strep can defy zinc toxicity

Vanderbilt researchers find that invasive Group B Streptococcus strains, a significant risk to pregnant patients and infants, can grow in presence of toxic zinc levels.
By Taylor Engdahl
November 15, 2021

Common questions about COVID vaccine and pregnancy

By Nancy Humphrey
October 29, 2021

HCV infection among pregnant people increasing

By Emily Stembridge
1 2 3 4 5 … 9